Compare JBL & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBL | CAH |
|---|---|---|
| Founded | 1966 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2B | 45.7B |
| IPO Year | 1998 | 1994 |
| Metric | JBL | CAH |
|---|---|---|
| Price | $352.36 | $216.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | ★ $272.33 | $232.27 |
| AVG Volume (30 Days) | 1.0M | ★ 2.0M |
| Earning Date | 06-16-2026 | 04-30-2026 |
| Dividend Yield | 0.10% | ★ 1.01% |
| EPS Growth | N/A | ★ 86.96 |
| EPS | ★ 3.43 | 1.88 |
| Revenue | $25,282,320,000.00 | ★ $222,578,000,000.00 |
| Revenue This Year | $15.81 | $17.36 |
| Revenue Next Year | $9.76 | $9.06 |
| P/E Ratio | ★ $105.65 | $113.12 |
| Revenue Growth | ★ 14.42 | N/A |
| 52 Week Low | $175.08 | $137.75 |
| 52 Week High | $384.70 | $233.60 |
| Indicator | JBL | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 49.81 | 70.62 |
| Support Level | $323.67 | $213.58 |
| Resistance Level | $378.54 | $216.06 |
| Average True Range (ATR) | 15.35 | 4.28 |
| MACD | -2.82 | 2.30 |
| Stochastic Oscillator | 27.67 | 88.30 |
Jabil Inc. is a U.S based company providing engineering, manufacturing, and supply chain solutions. It provides comprehensive electronics design, production, and product management services to companies in various industries and end markets. It operates through three segments: Regulated Industries, serving automotive, healthcare, and renewables; Intelligent Infrastructure, focused on AI, cloud, data centers, and communications, driving the majority of revenue; and Connected Living and Digital Commerce, specializing in digitalization and automation, such as robotics and warehouse automation. The company operates in the U.S., Mexico, China, Malaysia, Singapore, and several other markets.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.